Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|October 20, 2020
The Cannabinoid CB1 Receptor in SchizophreniaFaith Borgan, Michelle Kokkinou, Oliver Howes
Journal of Neurochemistry|September 19, 2017
Single cocaine exposure does not alter striatal pre-synaptic dopamine function in mice: an [18 F]-FDOPA PET studyDavid R Bonsall, Michelle Kokkinou, Mattia Veronese, et al.
Eneuro|May 17, 2018
Phasic Stimulation of Midbrain Dopamine Neuron Activity Reduces Salt ConsumptionEleanor C Sandhu, Anushka B P Fernando, Elaine E Irvine, et al.
Molecular Imaging and Biology|October 23, 2023
Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET StudyAlice Petty, Anna Garcia-Hidalgo, Els F Halff, et al.
Molecular Psychiatry|May 9, 2020
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamineMichelle Kokkinou, Elaine E Irvine, David R Bonsall, et al.
Journal of Psychopharmacology (Oxford, England)|August 21, 2025
Acute cannabidiol (CBD), tetrahydrocannabinol (THC) and their mixture (THC:CBD) exert differential effects on brain activity and blood flow in rats: A translational neuroimaging studyEilidh MacNicol, Michelle Kokkinou, Maria Elisa Serrano Navacerrada, et al.
Pageof 1